Browsing Category

65718 posts
GC Cell and BioCentriq® Execute Process Transfer Agreement in Anticipation of the U.S. entry of Immuncell-LC Inj.

GC Cell and BioCentriq® Execute Process Transfer Agreement in Anticipation of the U.S. entry of Immuncell-LC Inj.

Immuncell-LC Inj. is an autologous Cytokine Induced Killer (CIK) cell therapy approved…
GSMA MWC BARCELONA BRINGS INDUSTRIES TOGETHER FOR FOUR DAYS OF DISCUSSION AND DEBATE ON THE FUTURE OF CONNECTIVITY

GSMA MWC BARCELONA BRINGS INDUSTRIES TOGETHER FOR FOUR DAYS OF DISCUSSION AND DEBATE ON THE FUTURE OF CONNECTIVITY

MWC Barcelona 2024 welcomes the most iconic names in connectivity for nine…
OVER HALF OF AUSTRALIAN WOMEN FEEL THEIR PAIN IS IGNORED OR DISMISSED – HIGHLIGHTING NATIONAL GENDER PAIN GAP

OVER HALF OF AUSTRALIAN WOMEN FEEL THEIR PAIN IS IGNORED OR DISMISSED – HIGHLIGHTING NATIONAL GENDER PAIN GAP

New research from Nurofen reveals a national Gender Pain Gap in Australia…
Waters Announces Seamless HPLC/UPLC Data Bridge for Light Scattering, Integrating Essential Instruments for Large Molecule Characterization

Waters Announces Seamless HPLC/UPLC Data Bridge for Light Scattering, Integrating Essential Instruments for Large Molecule Characterization

News Summary: Waters now enables seamless connectivity between its liquid chromatography (LC)…
SAPEON collaborates with DOCOMO Innovations for AI services enhancement

SAPEON collaborates with DOCOMO Innovations for AI services enhancement

SAPEON collaborates with DOCOMO Innovations to conduct a PoC (Proof of Concept)…
Embracing a Bright Future: Appotronics Leads with Innovation and Sustainability in the Global Projection Market

Embracing a Bright Future: Appotronics Leads with Innovation and Sustainability in the Global Projection Market

SHENZHEN, China, Feb. 26, 2024 /PRNewswire/ — In a pivotal development for…
Aucta Pharmaceuticals, Inc. ("Aucta Pharmaceuticals") launches MOTPOLY XR™ (lacosamide) extended-release capsules C-V, the first, and only once-daily formulation of lacosamide

Aucta Pharmaceuticals, Inc. ("Aucta Pharmaceuticals") launches MOTPOLY XR™ (lacosamide) extended-release capsules C-V, the first, and only once-daily formulation of lacosamide

PISCATAWAY, N.J., Feb. 26, 2024 /PRNewswire/ — Aucta Pharmaceuticals, Inc., a private…
TransThera initiates IND-Enabling studies for TT-02332, a novel, highly potent and CNS-penetrating NLRP3 inhibitor

TransThera initiates IND-Enabling studies for TT-02332, a novel, highly potent and CNS-penetrating NLRP3 inhibitor

NANJING, China and GAITHURSBURG, Md., Feb. 26, 2024 /PRNewswire/ — TransThera, a clinical-stage…